Frontiers in Pharmacology (Jun 2023)
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
- Laura Grohs,
- Laura Grohs,
- Linhan Cheng,
- Saskia Cönen,
- Saskia Cönen,
- Bassam G. Haddad,
- Astrid Bülow,
- Astrid Bülow,
- Idil Toklucu,
- Lisa Ernst,
- Jannis Körner,
- Jannis Körner,
- Günther Schmalzing,
- Angelika Lampert,
- Jan-Philipp Machtens,
- Jan-Philipp Machtens,
- Ralf Hausmann
Affiliations
- Laura Grohs
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Laura Grohs
- Department of Neurology, University Hospital, RWTH Aachen University, Aachen, Germany
- Linhan Cheng
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Saskia Cönen
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Saskia Cönen
- Molecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, Germany
- Bassam G. Haddad
- Molecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, Germany
- Astrid Bülow
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Astrid Bülow
- Department of Plastic Surgery, Hand and Burn Surgery, University Hospital RWTH Aachen, Aachen, Germany
- Idil Toklucu
- Institute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany
- Lisa Ernst
- Institute for Laboratory Animal Science and Experimental Surgery, RWTH Aachen University, Aachen, Germany
- Jannis Körner
- Institute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany
- Jannis Körner
- Department of Anesthesiology, University Hospital RWTH Aachen, Aachen, Germany
- Günther Schmalzing
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Angelika Lampert
- Institute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, Germany
- Jan-Philipp Machtens
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- Jan-Philipp Machtens
- Molecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, Germany
- Ralf Hausmann
- Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germany
- DOI
- https://doi.org/10.3389/fphar.2023.1225522
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
- P2X3 receptor
- nociception
- chronic pain
- non-steroidal anti-inflammatory drugs (NSAIDs)
- competitive antagonist
- drug screening